These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18350493)

  • 1. [Rapamycin and lymphangiogenesis: side effect or treatment result?].
    Stallone G
    G Ital Nefrol; 2008; 25(2):157. PubMed ID: 18350493
    [No Abstract]   [Full Text] [Related]  

  • 2. How to control lymphangiogenesis: a novel role for rapamycin.
    Kerjaschki D
    Kidney Int; 2007 Apr; 71(8):717-9. PubMed ID: 17429417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of rapamycin.
    Ley SV; Tackett MN; Maddess ML; Anderson JC; Brennan PE; Cappi MW; Heer JP; Helgen C; Kori M; Kouklovsky C; Marsden SP; Norman J; Osborn DP; Palomero MA; Pavey JB; Pinel C; Robinson LA; Schnaubelt J; Scott JS; Spilling CD; Watanabe H; Wesson KE; Willis MC
    Chemistry; 2009; 15(12):2874-914. PubMed ID: 19204960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rapamycin on lifespan in Drosophila.
    Harrison B; Tran TT; Taylor D; Lee SD; Min KJ
    Geriatr Gerontol Int; 2010 Jan; 10(1):110-2. PubMed ID: 20102391
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell lines.
    Heuer M; Benkö T; Cicinnati VR; Kaiser GM; Sotiropoulos GC; Baba HA; Treckmann JW; Broelsch CE; Paul A
    Transplant Proc; 2009; 41(1):359-65. PubMed ID: 19249557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin and dendritic cells: keep on movin'.
    Hackstein H
    Transplantation; 2006 Sep; 82(6):739-40. PubMed ID: 17006318
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapamycin inhibits poly(ADP-ribosyl)ation in intact cells.
    Fahrer J; Wagner S; Bürkle A; Königsrainer A
    Biochem Biophys Res Commun; 2009 Aug; 386(1):232-6. PubMed ID: 19523443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin--rather than FK506--might promote allograft tolerance induced by CD4+CD25+ regulatory T cells.
    Du JF; Li SY; Yu B
    Surgery; 2009 Sep; 146(3):526-7; author reply 527-8. PubMed ID: 19715817
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin attenuates the severity of murine adriamycin nephropathy.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus: a new immunosuppressant.
    Mukherjee T; Shah BV
    J Assoc Physicians India; 2005 Oct; 53():885-90. PubMed ID: 16459533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus in pediatric solid organ transplantation.
    Dharnidharka VR
    Pediatr Transplant; 2005 Aug; 9(4):427-9. PubMed ID: 16048592
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.
    Chang GR; Wu YY; Chiu YS; Chen WY; Liao JW; Hsu HM; Chao TH; Hung SW; Mao FC
    Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):188-98. PubMed ID: 19496779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors.
    Cruzado JM
    Transplant Rev (Orlando); 2008 Jan; 22(1):73-81. PubMed ID: 18631860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs.
    Graziani EI
    Nat Prod Rep; 2009 May; 26(5):602-9. PubMed ID: 19387497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and overadditive effects of rapamycin and FTY720 in pancreatic cancer cells in vitro.
    Shen Y; Wang X; Xia W; Wang C; Cai M; Xie H; Zhou L; Zheng S
    Transplant Proc; 2008 Jun; 40(5):1727-33. PubMed ID: 18589181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
    Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
    Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [To stay immature: the first step to tolerate?].
    Grosjean F
    G Ital Nefrol; 2008; 25(4):383. PubMed ID: 18663680
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
    Shi J; Jun W; Zhao LY; Xue YX; Zhang XY; Kosten TR; Lu L
    Eur J Pharmacol; 2009 Aug; 615(1-3):108-12. PubMed ID: 19470385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.